Preparation, optimization, and evaluation of Zaltoprofen-loaded microemulsion and microemulsion-based gel for transdermal delivery

Journal of Liposome Research

Volumn 26, Issue 4, 2016, Pages 297-306

  Mishra, Ratnesh ^a   Prabhavalkar, Kedar S ^b   Bhatt, Lokesh Kumar ^b  

^a Department of Quality Assurance ^*  (India)

^b SVKM S DR BHANUBEN NANAVATI COLLEGE OF PHARMACY   (India)

Author keywords

Analgesic; microemulsion based gel; Zaltoprofen

Indexed keywords

CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; SURFACTANT; ZALTOPROFEN; ANALGESIC AGENT; BENZOPYRAN DERIVATIVE; EMULSION; GEL; NONSTEROID ANTIINFLAMMATORY AGENT; PROPIONIC ACID DERIVATIVE; PYRANOPROFEN;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISPERSITY; DRUG FORMULATION; DRUG PENETRATION; DRUG SCREENING; EXPERIMENTAL PAW EDEMA; GEL; HOT PLATE TEST; MICROEMULSION; NONHUMAN; PIG; PRIORITY JOURNAL; RAT; TRANSDERMAL DRUG DELIVERY SYSTEM; VISCOMETRY; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; CUTANEOUS DRUG ADMINISTRATION; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; EMULSION; INFLAMMATION; KINETICS; MEDICINAL CHEMISTRY; PAIN; PHARMACOKINETICS; SKIN; SKIN ABSORPTION; WISTAR RAT;

ADMINISTRATION, CUTANEOUS; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOPYRANS; CHEMISTRY, PHARMACEUTICAL; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; EMULSIONS; GELS; INFLAMMATION; KINETICS; PAIN; PROPIONATES; RATS; RATS, WISTAR; SKIN; SKIN ABSORPTION; SURFACE-ACTIVE AGENTS;

EID: 84954528409     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2015.1120746     Document Type: Article

References (28)

1. D.Attwood (1994) Microemulsions. In:J.Kreuter, ed. Colloidal drug delivery systems. New York:Marcel Dekker, 31–71
2. M.M.Badran, J.Kuntsche, A.Fahr (2009). Skin penetration enhancement by a microneedle device (Dermaroller) in vitro:dependency on needle size and applied formulation. Eur J Pharm Sci 36:511–23
3. J.S.Baek, J.H.Lim, J.S.Kang,. (2013). Enhanced transdermal drug delivery of zaltoprofen using a novel formulation. Int J Pharm 453:358–62
4. A.K.Baker, V.L.H.Hoffmann, T.F.Meert (2002). Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain. Pharmacol Biochem Behav 74:73–86
5. J.S.Bang, D.H.Oh, H.M.Choi,. (2009). Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res Ther 11:R49
6. M.A.Bolzinger, S.Brianc, J.Pelletier,. (2008). Percutaneous release of caffeine from microemulsion, emulsion and gel dosage forms. Eur J Pharm Biopharm 68:446–51
7. A.Chatterjee, M.S.Varshney, M.Himanshu,. (2014). Formulation and in-vitro characterization of zaltoprofen transdermal patch using different polymers. Int J Pharm Sci Rev Res 27:277
8. H.Chen, X.Chang, D.Du,. (2006). Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int J Pharm 315:52–8
9. Farshid AB, Tamaddonfard E, Yahyaee F. (2010). Effects of histidine and N-acetylcysteine on diclofenac-induced anti-inflammatory response in acute inflammation in rats. Ind J Exp Biol 48:1136–42
10. Y.A.Gomaa, L.K.El-Khordagui, M.J.Garland,. (2012). Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye. J Pharm Pharmacol 64:1592–602
11. R.M.Hathout, A.H.Elshafeey (2012). Development and characterization of colloidal soft nano-carriers for transdermal delivery and bioavailability enhancement of an angiotensin II receptor blocker. Eur J Pharm Biopharm 82:230–40
12. R.J.Hunter (1981). Zeta potential in colloid science. New York:Academic Press
13. S.Kawai (1998). Cyclooxygenase selectivity and the risk of gastro-intestinal complications of various non-steroidal anti-inflammatory drugs:a clinical consideration. Inflamm Res 47:102–6
14. S.Khurana, N.K.Jain, P.M.Bedi (2013). Nanoemulsion based gel for transdermal delivery of meloxicam:physico-chemical, mechanistic investigation. Life Sci 92:383–92
15. M.J.Lawrence, G.D.Rees (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45:89–121
16. L.Li, P.Ma, Y.Cao,. (2011). Single-dose and multiple dose pharmacokinetics of zaltoprofen after oral administration in healthy Chinese volunteers. J Biomed Res 25:56–62
17. J.Malakar, A.K.Nayak, A.Basu (2012). Ondansetron HCl microemulsions for transdermal delivery:formulation and in vitro skin permeation. ISRN Pharm 2012:428396
18. M.Matsumoto, M.Inoue, H.Ueda (2006). NSAID zaltoprofen possesses novel anti-nociceptive mechanism through blockage of B2-type bradykinin receptor in nerve endings. Neurosci Lett 397:249–53
19. M.N.Mutimer, C.Riffkin, J.A.Hill,. (1956). Modern ointment bases technology–II – comparative evaluation of bases. J Am Pharm Assoc 15:212–18
20. T.Ogiso, N.Niinaka, M.Iwaki (1996). Mechanism for enhancement effect of lipid disperse system on percutaneous absorption. J Pharm Sci 85:57–64
21. M.A.Polizelli, V.R.N.Telis, L.Q.Amaral, E.Feitosa (2006). Formation and characterization of soy bean oil/surfactant/water microemulsions. Colloids Surf A 281:230–6
22. E.Ricciotti, G.A.FitzGerald (2011). Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 31:986–1000
23. M.Senye, C.F.Mir, S.Morton, N.M.Thie (2012). Topical nonsteroidal anti-inflammatory medications for treatment of temporomandibular joint degenerative pain:a systematic review. J Orofac Pain 26:26–32
24. K.Tsurumi, K.Kyuki, M.Niwa,. (1986). Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b, f]thiepin-2-yl)propionic acid. 1st communication:inhibitory effects of rat paw edema. Arzneimittelforschung 36:1796–800
25. C.A.Winter, E.A.Risley, C.W.Nuss (1962). Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 111:544–7
26. J.H.Wood, G.Catacalos, S.V.Lieberman (1963). Adaptation of commercial viscometers for special applications in pharmaceutical rheology. II. Severs extrusion rheometer. J Pharm Sci 52:375–8
27. Y.Yue, L.San-Ming, D.Pan, Z.Da-Fang (2007). Physicochemical properties and evaluation of microemulsion systems for transdermal delivery of meloxicam. Chem Res Chin Univ 23:81–6
28. A.Zarghi, S.Arfaei (2011). Selective COX-2 inhibitors:a review of their structure-activity relationships. Iran J Pharm Res 10:655–83